| Page 236 | Kisaco Research

BCBS Rhode Island

I learned so much from this event and met so many new connections. It was wonderful to hear different perspectives and learn about new opportunities!

Point32Health

I learned so much at this event from the top experts in the field! This event also made me think of new and innovative ideas from listening to all of the various speakers  

 

Thomas Carter

Commercial Partnerships Manager

Contact me on: [email protected]

Thomas Carter

Commercial Partnerships Manager

Thomas Carter

Commercial Partnerships Manager

Contact me on: [email protected]

 

Ryan Sanderson

Partnerships Director

Contact me on: [email protected]

Ryan Sanderson

Partnerships Director

Ryan Sanderson

Partnerships Director

Contact me on: [email protected]

 

Matthew Bray

Commercial Partnerships Manager, Life Sciences

Matthew Bray

Commercial Partnerships Manager, Life Sciences

Matthew Bray

Commercial Partnerships Manager, Life Sciences
 

Charles Sheppard

Sponsorship Director, Animal Health, Healthcare and Life Sciences
Kisaco Research

Find out more by calling us at +44 (0)20 3696 2920 or email Charles Sheppard at [email protected]

Charles Sheppard

Sponsorship Director, Animal Health, Healthcare and Life Sciences
Kisaco Research

Charles Sheppard

Sponsorship Director, Animal Health, Healthcare and Life Sciences
Kisaco Research

Find out more by calling us at +44 (0)20 3696 2920 or email Charles Sheppard at [email protected]

Mariana Oncology

I found the conference to be comprehensive, delving into various facets of AI applications in drug discovery, ranging from target identification to the analysis of clinical trial data. The speakers provided valuable insights, and I gained a wealth of knowledge from their presentations. Additionally, the event afforded me the opportunity to network with experts in the field, further enhancing my understanding and connections within this dynamic industry.

Nobias Therapeutics

This was a great opportunity to connect closely with practitioners in the AI drug discovery space. The quality of presentations, speakers, and panels was high, and it's really great to hear what different groups are doing at the forefront of our industry.